Signos Inc
Signos Inc
Explore linked clinical trials.3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Signos DM2 Empowerment Study (SIGNOS-CGM-EMPOWER-201-2022) | Body Weight, Body Weight Changes, Insulin Resistance, Nutritional and Metabolic Diseases, Obesity, Abdominal, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Weight Loss, diabetes mellitus, endocrine system disorder, glucose intolerance, glucose metabolism disease, hyperglycemia, hyperinsulinism, metabolic disease, nutritional disorder, obesity disorder, overnutrition, type 2 diabetes mellitus | Active, not recruiting | Not applicable | 2025-08-29 | NCT05874635 | |
| Use of Continuous Glucose Monitoring in Non-Diabetic Population to Compliment Signos Mobile Health Platform | Body Weight, Body Weight Changes, Insulin Resistance, Nutritional and Metabolic Diseases, Obesity, Abdominal, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Weight Loss, glucose intolerance, glucose metabolism disease, hyperglycemia, hyperinsulinism, metabolic disease, nutritional disorder, obesity disorder, overnutrition | Active, not recruiting | Not applicable | 2025-08-24 | NCT05121844 | |
| Using Signos mHealth Platform in Adults for Weight Management | Body Weight, Body Weight Changes, Insulin Resistance, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Weight Loss, glucose metabolism disease, hyperinsulinism, metabolic disease, nutritional disorder, obesity disorder, overnutrition | Active, not recruiting | Not applicable | 2024-10-08 | NCT06214221 |